Related Experiment Video

Updated: Aug 19, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Myocardial damage following infarction

R M Norris

    Comprehensive Therapy
    |November 1, 1978
    PubMed

    Insights

    Infarct size significantly impacts survival after acute myocardial infarction (MI). While bedside methods and chest X-rays offer some assessment, measuring released enzymes like CK shows the most promise for accurate infarct size determination.

    Area of Science:

    • Cardiology
    • Medical Imaging
    • Biochemical Markers

    Background:

    • Acute myocardial infarction (MI) prognosis is strongly linked to infarct size.
    • Accurate infarct size assessment is crucial for patient management and survival prediction.
    • Current methods for infarct size measurement have limitations.

    Purpose of the Study:

    • To review current methods for assessing infarct size in acute MI.
    • To evaluate the effectiveness of different diagnostic techniques.
    • To identify promising future directions for infarct size measurement.

    Main Methods:

    • Review of existing literature on infarct size assessment in acute MI.
    • Analysis of bedside techniques and chest radiography interpretation.
    • Evaluation of hemodynamic monitoring using Swan-Ganz catheters.
    • Assessment of biochemical markers, specifically creatine kinase (CK) enzyme levels.

    Main Results:

    • Bedside techniques and chest radiography provide initial infarct size estimations.
    • Swan-Ganz thermodilution catheters offer sensitive hemodynamic status assessment.
    • No single method is currently entirely satisfactory for precise infarct size measurement.
    • Measurement of metabolic substances, particularly CK enzyme, shows significant promise.

    Conclusions:

    • Infarct size is a critical determinant of survival in acute MI.
    • A combination of clinical assessment and advanced monitoring is currently employed.
    • Further research is needed to develop accurate and reliable methods for infarct size quantification.
    • Biomarker analysis, especially CK enzyme, represents a promising avenue for future development.

    More Related Videos

    Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice09:05

    Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

    Published on: May 4, 2015

    A Cryoinjury Model to Study Myocardial Infarction in the Mouse06:29

    A Cryoinjury Model to Study Myocardial Infarction in the Mouse

    Published on: September 19, 2019

    Related Concept Videos

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers

    Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
    The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
    Troponins
    Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

    The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...